ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Educational Symposium

Novel Therapeutic Options in Hyperkalemia

October 25, 2020 | 01:00 PM - 02:00 PM

Location: Simulive

Session Description

Hyperkalemia is a common clinical challenge when treating patients with CKD. In addition to the acute management that is required, recurrent hyperkalemia limits the use of such proven therapies as RAAS inhibitors.

This symposium provides an update on recent advances in the treatment of acute and chronic hyperkalemia. In addition to the epidemiology of hyperkalemia, discussion includes the clinical use of novel potassium-lowering agents.

Support is provided by an educational grant from AstraZeneca Pharmaceuticals.

Learning Objective(s)

  • Describe the incidence, risk factors, and adverse outcomes associated with hyperkalemia
  • Discuss treatment options for hyperkalemia, including the efficacy and safety of novel agents
  • Describe therapeutic strategies that can minimize hyperkalemia as a barrier to the use of proven regimens that lower the risk of cardiovascular and kidney diseases

Learning Pathway(s)

  • Bone and Mineral Metabolism
  • Chronic Kidney Disease


  • Niraj Desai, MD


  • Introduction
    01:00 PM - 01:10 PM
    Niraj Desai, MD 
  • Risk Factors and Outcomes of Hyperkalemia
    01:10 PM - 01:35 PM
    Jerry Yee, MD, FASN
  • New Therapeutic Options in Hyperkalemia
    01:35 PM - 02:00 PM
    Faiez Zannad, MD, PhD